Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β

Human Molecular Genetics

Volumn 21, Issue 12, 2012, Pages 2725-2737

  Park, Hyejin ^a   Kam, Tae In ^a   Kim, Youngdoo ^a   Choi, Hyunwoo ^a   Gwon, Youngdae ^a   Kim, Changsoo ^b   Koh, Jae Young ^c   Jung, Yong Keun ^a  

^a Seoul National University   (South Korea)

^b Chonnam National University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; AMYLOID BETA PROTEIN[1-42]; EPITOPE; GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE MODEL; DOWN REGULATION; DROSOPHILA; ENZYME ACTIVITY; EYE; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TAUOPATHY;

ADENYLATE KINASE; ALZHEIMER DISEASE; AMP-ACTIVATED PROTEIN KINASES; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; DROSOPHILA; DROSOPHILA PROTEINS; GLYCOGEN SYNTHASE KINASE 3; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HIPPOCAMPUS; HUMANS; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; NEURODEGENERATIVE DISEASES; NEURONS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RNA INTERFERENCE; TAU PROTEINS;

MUS;

EID: 84861738869     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds100     Document Type: Article

References (50)

1. Querfurth, H.W. and LaFerla, F.M. (2010) Alzheimer's disease. N. Engl. J. Med., 362, 329-344.
2. Grundke-Iqbal, I., Iqbal, K., George, L., Tung, Y.C., Kim, K.S. and Wisniewski, H.M. (1989) Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc. Natl Acad. Sci. USA, 86, 2853-2857.
3. Ballatore, C., Lee, V.M. and Trojanowski, J.Q. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci., 8, 663-672.
4. Haass, C. and Selkoe, D.J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol., 8, 101-112.
5. Hardy, J. and Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297, 353-356.
6. Lewis, J., Dickson, D.W., Lin, W.L., Chisholm, L., Corral, A., Jones, G., Yen, S.H., Sahara, N., Skipper, L., Yager, D. et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science, 293, 1487-1491.
7. 42 fibrils. Science, 293, 1491-1495.
8. Oddo, S., Billings, L., Kesslak, J.P., Cribbs, D.H. and LaFerla, F.M. (2004) Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron, 43, 321-332.
9. Lucas, J.J., Hernández, F., Gómez-Ramos, P., Morán, M.A., Hen, R. and Avila, J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J., 20, 27-39.
10. Noble, W., Olm, V., Takata, K., Casey, E., Mary, O., Meyerson, J., Gaynor, K., LaFrancois, J., Wang, L., Kondo, T. et al. (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron, 38, 555-565.
11. Drewes, G., Ebneth, A., Preuss, U., Mandelkow, E.M. and Mandelkow, E. (1997) MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell, 89, 297-308.
12. Hanger, D.P., Hughes, K., Woodgett, J.R., Brion, J.P. and Anderton, B.H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett., 147, 58-62.
13. Ishizawa, T., Sahara, N., Ishiguro, K., Kersh, J., McGowan, E., Lewis, J., Hutton, M., Dickson, D.W. and Yen, S.H. (2003) Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Am. J. Pathol., 163, 1057-1067.
14. Engel, T., Lucas, J.J., Gómez-Ramos, P., Moran, M.A., Avila, J. and Hernández, F. (2006) Coexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration. Neurobiol. Aging, 27, 1258-1268.
15. Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B. et al. (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl Acad. Sci. USA, 102, 6990-6995.
16. Mudher, A., Shepherd, D., Newman, T.A., Mildren, P., Jukes, J.P., Squire, A., Mears, A., Drummond, J.A., Berg, S., MacKay, D. et al. (2004) GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol. Psychiatry, 9, 522-530.
17. Takashima, A., Noguchi, K., Sato, K., Hoshino, T. and Imahori, K. (1993) Tau protein kinase 1 is essential for amyloid beta-protein-induced neurotoxicity. Proc. Natl Acad. Sci. USA, 90, 7789-7793.
18. Terwel, D., Muyllaert, D., Dewachter, I., Borghgraef, P., Croes, S., Devijver, H. and Van Leuven, F. (2008) Amyloid activates GSK 3beta to aggravate neuronal tauopathy in bigenic mice. Am. J. Pathol., 173, 786-798.
19. Noma, T. (2005) Dynamics of nucleotide metabolism as a supporter of life phenomena. J. Med. Invest., 52, 127-136.
20. Dzeja, P. and Terzic, A. (2009) Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing. Int. J. Mol. Sci., 10, 1729-1772.
21. Tanabe, T., Yamada, M., Noma, T., Kajii, T. and Nakazawa, A. (1993) Tissue-specific and developmentally regulated expression of the genes encoding adenylate kinase isozymes. J. Biochem., 113, 200-207.
22. Collavin, L., Lazarevic, D., Utrera, R., Marzinotto, S., Monte, M. and Schneider, C. (1999) wt p53 dependent expression of a membrane-associated isoform of adenylate kinase. Oncogene, 18, 5879-5888.
23. Janssen, E., Kuiper, J., Hodgson, D., Zingman, L.V., Alekseev, A.E., Terzic, A. and Wieringa, B. (2004) Two structurally distinct and spatially compartmentalized adenylate kinases are expressed from the AK1 gene in mouse brain. Mol. Cell. Biochem., 256, 59-72.
24. Janssen, E., Dzeja, P.P., Oerlemans, F., Simonetti, A.W., Heerschap, A., de Haan, A., Rush, P.S., Terjung, R.R., Wieringa, B. and Terzic, A. (2000) Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. EMBO J., 19, 6371-6381.
25. Brooks, W.M., Lynch, P.J., Ingle, C.C., Hatton, A., Emson, P.C., Faull, R.L. and Starkey, M.P. (2007) Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease. Brain Res., 1127, 127-135.
26. Liang, W.S., Reiman, E.M., Valla, J., Dunckley, T., Beach, T.G., Grover, A., Niedzielko, T.L., Schneider, L.E., Mastroeni, D., Caselli, R. et al. (2008) Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc. Natl Acad. Sci. USA, 105, 4441-4446.
27. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science, 4, 99-103.
28. Mucke, L., Masliah, E., Yu, G.Q., Mallory, M., Rockenstein, E.M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K. and McConlogue, L. (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci., 20, 4050-4058.
29. Zempel, H., Thies, E., Mandelkow, E. and Mandelkow, E.M. (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci., 30, 11938-11950.
30. Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D. and Selkoe, D.J. (2011) Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce tau hyperphosphorylation and neuritic degeneration. Proc. Natl Acad. Sci. USA, 108, 5819-5824.
31. Kim, H.J., Nishikawa, S., Tokutomi, Y., Takenaka, H., Hamada, M., Kuby, S.A. and Uesugi, S. (1990) In vitro mutagenesis studies at the arginine residues of adenylate kinase. A revised binding site for AMP in the X-ray-deduced model. Biochemistry, 29, 1107-1111.
32. Horike, N., Sakoda, H., Kushiyama, A., Ono, H., Fujishiro, M., Kamata, H., Nishiyama, K., Uchijima, Y., Kurihara, Y., Kurihara, H. et al. (2008) AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver. J. Biol. Chem., 283, 33902-33910.
33. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N. et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest., 108, 1167-1174.
34. Corton, J.M., Gillespie, J.G., Hawley, S.A. and Hardie, D.G. (1995) 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem., 229, 558-565.
35. Jackson, G.R., Wiedau-Pazos, M., Sang, T.K., Wagle, N., Brown, C.A., Massachi, S. and Geschwind, D.H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron, 16, 509-519.
36. Wittmann, C.W., Wszolek, M.F., Shulman, J.M., Salvaterra, P.M., Lewis, J., Hutton, M. and Feany, M.B. (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science, 293, 711-714.
37. Hancock, C.R., Janssen, E. and Terjung, R.L. (2005) Skeletal muscle contractile performance and ADP accumulation in adenylate kinase-deficient mice. Am. J. Physiol. Cell Physiol., 288, C1287-C1297.
38. Steinberg, G.R. and Kemp, B.E. (2009) AMPK in health and disease. Physiol. Rev., 89, 1025-1078.
39. Ronnett, G.V., Ramamurthy, S., Kleman, A.M., Landree, L.E. and Aja, S. (2009) AMPK in the brain: its roles in energy balance and neuroprotection. J. Neurochem., 109, 17-23.
40. Greco, S.J., Sarkar, S., Johnston, J.M. and Tezapsidis, N. (2009) Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochem. Biophys. Res. Commun., 380, 98-104.
41. Thornton, C., Bright, N.J., Sastre, M., Muckett, P.J. and Carling, D. (2011) AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid b-peptide exposure. Biochem. J., 434, 503-512.
42. Dzeja, P.P., Chung, S., Faustino, R.S., Behfar, A. and Terzic, A. (2011) Developmental enhancement of adenylate kinase-AMPK metabolic signaling axis supports stem cell cardiac differentiation. PLoS One, 6, e19300.
43. Xiao, B., Sanders, M.J., Underwood, E., Heath, R., Mayer, F.V., Carmena, D., Jing, C., Walker, P.A., Eccleston, J.F., Haire, L.F. et al. (2011) Structure of mammalian AMPK and its regulation by ADP. Nature, 472, 230-233.
44. Oakhill, J.S., Steel, R., Chen, Z.P., Scott, J.W., Ling, N., Tam, S. and Kemp, B.E. (2011) AMPK is a direct adenylate charge-regulated protein kinase. Science, 332, 1433-1435.
45. Chung, C.W., Song, Y.H., Kim, I.K., Yoon, W.J., Ryu, B.R., Jo, D.G., Woo, H.N., Kwon, Y.K., Kim, H.H., Gwag, B.J. et al. (2001) Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol. Dis., 8, 162-172.
46. He, T.C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W. and Vogelstein, B. (1998) A simplified system for generating recombinant adenovirus. Proc. Natl Acad. Sci. USA, 95, 2509-2514.
47. Goedert, M., Spillantini, M.G., Cairns, N.J. and Crowther, R.A. (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron, 8, 159-168.
48. Song, S., Kim, S.Y., Hong, Y.M., Jo, D.G., Lee, J.Y., Shim, S.M., Chung, C.W., Seo, S.J., Yoo, Y.J., Koh, J.Y. et al. (2003) Essential role of E2-25K/Hip-2 in mediating amyloid-beta neurotoxicity. Mol. Cell, 12, 553-563.
49. Detimary, P., Jonas, J.C. and Henquin, J.C. (1995) Possible links between glucose-induced changes in the energy state of pancreatic B cells and insulin release. J. Clin. Invest., 96, 1738-1745.
50. Witters, L.A. and Kemp, B.E. (1992) Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase. J. Biol. Chem., 267, 2864-2867.